BIIB
Price
$185.68
Change
+$0.90 (+0.49%)
Updated
Oct 4 closing price
24 days until earnings call
OGN
Price
$18.29
Change
+$0.03 (+0.16%)
Updated
Oct 4 closing price
25 days until earnings call
Ad is loading...

BIIB vs OGN

Header iconBIIB vs OGN Comparison
Open Charts BIIB vs OGNBanner chart's image
Biogen
Price$185.68
Change+$0.90 (+0.49%)
Volume$1.14M
CapitalizationN/A
Organon & Co
Price$18.29
Change+$0.03 (+0.16%)
Volume$2.18M
CapitalizationN/A
View a ticker or compare two or three
BIIB vs OGN Comparison Chart
Loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BIIB vs. OGN commentary
Oct 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and OGN is a StrongSell.

COMPARISON
Comparison
Oct 06, 2024
Stock price -- (BIIB: $185.68 vs. OGN: $18.29)
Brand notoriety: BIIB: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BIIB: 106% vs. OGN: 112%
Market capitalization -- BIIB: $31.34B vs. OGN: $4.73B
BIIB [@Pharmaceuticals: Major] is valued at $31.34B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIIB’s FA Score shows that 1 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • BIIB’s FA Score: 1 green, 4 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, OGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIIB’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • BIIB’s TA Score: 4 bullish, 4 bearish.
  • OGN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BIIB is a better buy in the short-term than OGN.

Price Growth

BIIB (@Pharmaceuticals: Major) experienced а -4.62% price change this week, while OGN (@Pharmaceuticals: Major) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.89%. For the same industry, the average monthly price growth was -2.16%, and the average quarterly price growth was +7.10%.

Reported Earning Dates

BIIB is expected to report earnings on Jan 30, 2025.

OGN is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.89% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIIB($31.3B) has a higher market cap than OGN($4.73B). BIIB has higher P/E ratio than OGN: BIIB (26.95) vs OGN (4.64). OGN YTD gains are higher at: 32.397 vs. BIIB (-28.245). BIIB has higher annual earnings (EBITDA): 2.04B vs. OGN (1.44B). BIIB has more cash in the bank: 1.05B vs. OGN (693M). BIIB has less debt than OGN: BIIB (7.34B) vs OGN (8.76B). BIIB has higher revenues than OGN: BIIB (9.84B) vs OGN (6.26B).
BIIBOGNBIIB / OGN
Capitalization31.3B4.73B662%
EBITDA2.04B1.44B142%
Gain YTD-28.24532.397-87%
P/E Ratio26.954.64581%
Revenue9.84B6.26B157%
Total Cash1.05B693M152%
Total Debt7.34B8.76B84%
FUNDAMENTALS RATINGS
BIIB: Fundamental Ratings
BIIB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIIBOGN
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
64%
Advances
ODDS (%)
Bullish Trend 10 days ago
55%
Bullish Trend 10 days ago
68%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
57%
Aroon
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
65%
View a ticker or compare two or three
Ad is loading...
BIIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBL25.300.34
+1.36%
CBL & Associates Properties
SXT77.500.82
+1.07%
Sensient Technology Corp
LW68.850.56
+0.82%
Lamb Weston Holdings
STHO13.00-0.15
-1.14%
Star Holdings
OLB2.50-0.27
-9.75%
OLB Group Inc. (The)

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+0.49%
AMGN - BIIB
42%
Loosely correlated
+0.69%
OGN - BIIB
35%
Loosely correlated
+0.16%
GILD - BIIB
34%
Loosely correlated
+0.50%
AZN - BIIB
32%
Poorly correlated
-0.59%
NVS - BIIB
30%
Poorly correlated
+0.16%
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+0.16%
BIIB - OGN
36%
Loosely correlated
+0.49%
PFE - OGN
32%
Poorly correlated
+0.85%
NVS - OGN
30%
Poorly correlated
+0.16%
AMRN - OGN
29%
Poorly correlated
+2.14%
JNJ - OGN
26%
Poorly correlated
-0.13%
More